Severe hypertension following accidental clonidine overdose during the refilling of an implanted intrathecal drug delivery system.
Détails
ID Serval
serval:BIB_D490A880D4CE
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Severe hypertension following accidental clonidine overdose during the refilling of an implanted intrathecal drug delivery system.
Périodique
Neuromodulation
ISSN
1525-1403 (Electronic)
ISSN-L
1094-7159
Statut éditorial
Publié
Date de publication
2012
Volume
15
Numéro
1
Pages
31-34
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article
Résumé
BACKGROUND: Complications associated with intrathecal pumps may be linked to the surgical procedure, the implanted device, or the medication itself.¦CASE REPORTS: Three patients treated chronically with intrathecal clonidine presented with clonidine overdose due to inadvertent extravasation during the refilling procedure. All patients experienced loss of consciousness and severe systemic hypertension that required aggressive parenteral treatment.¦DISCUSSION: Clonidine is an alpha-2 agonist with a nearly 100% bioavailability after oral or rectal administration. With high plasma concentration secondary to massive systemic overdose, the specificity for the alpha-2 receptor is lost and an alpha-1 agonist activity predominates and causes marked hypertension. Management of clonidine overdose consists of supportive therapy guided by signs and symptoms.¦CONCLUSION: Inadvertent injection into the subcutaneous pocket rather than the reservoir is rare but very dangerous as the drug cannot be retrieved and massive doses are involved. Signs and symptoms of systemic overdose with drugs commonly used in implanted drugs delivery system should be well known to ensure early diagnosis and treatment.
Mots-clé
Adrenergic alpha-2 Receptor Agonists/adverse effects, Aged, Clonidine/adverse effects, Drug Delivery Systems, Female, Humans, Hypertension/chemically induced, Infusion Pumps, Implantable/adverse effects, Injections, Spinal/methods, Low Back Pain/drug therapy, Male, Middle Aged, Overdose
Pubmed
Web of science
Création de la notice
31/05/2012 18:06
Dernière modification de la notice
20/08/2019 15:54